Skip To Main Content

Science at Sanofi

Sort by

Filter

Reset
  • Therapeutical Areas
High-Dose Influenza Vaccine in Older Adults by Age and Seasonal Characteristics: Systematic Review and Meta-Analysis Update

High-Dose Influenza Vaccine in Older Adults by Age and Seasonal Characteristics: Systematic Review and Meta-Analysis Update

Burden of Respiratory Syncytial Virus Infection During the First Year of Life.

Burden of Respiratory Syncytial Virus Infection During the First Year of Life.

Immunogenicity and Safety of High-Dose Quadrivalent Influenza Vaccine in Older Adults in Taiwan: A Phase Iii, Randomized, Multi-Center Study

Immunogenicity and Safety of High-Dose Quadrivalent Influenza Vaccine in Older Adults in Taiwan: A Phase Iii, Randomized, Multi-Center Study

Health care professionals’ preference for a fully liquid, ready-to-use hexavalent vaccine in Spain

Health care professionals’ preference for a fully liquid, ready-to-use hexavalent vaccine in Spain

The impact of influenza vaccination on cardiovascular disease

The impact of influenza vaccination on cardiovascular disease

Impact of Tdap vaccine during pregnancy on the incidence of pertussis in children under one year in Brazil - A time series analysis

Impact of Tdap vaccine during pregnancy on the incidence of pertussis in children under one year in Brazil - A time series analysis

 A time and motion study.

A time and motion study.

Preparation of the fully-liquid hexavalent vaccine took approximately 50% less time than required to prepare the non-fully liquid vaccine.

Global, Regional and National Estimates of Influenza-Attributable Ischemic Heart Disease Mortality

Global, Regional and National Estimates of Influenza-Attributable Ischemic Heart Disease Mortality

วิจัยเผย! หากไร้โรคไข้หวัดใหญ่ อาจลดความเสี่ยงเสียชีวิตจากโรคหัวใจขาดเลือดได้ถึง 4%

A Lower Level of Post-Vaccinal Antibody Titer against Influenza Virus A H1N1 May Protect Patients with Autoimmune Rheumatic Diseases from Respiratory Viral Infections

A Lower Level of Post-Vaccinal Antibody Titer against Influenza Virus A H1N1 May Protect Patients with Autoimmune Rheumatic Diseases from Respiratory Viral Infections

ฉีดวัคซีนป้องกันไข้หวัดใหญ่ ป้องกันการติดเชื้อโรคทางเดินหายใจในกลุ่มผู้สูงอายุ Autoimmune ได้จริง

Rates and risk factors of severe respiratory syncytial virus infection in 2008-2016 compared with 1986-1998

Rates and risk factors of severe respiratory syncytial virus infection in 2008-2016 compared with 1986-1998

เทียบชัด ๆ ของไวรัส RSV! รุนแรงแค่ไหน? ในยุคก่อนและหลังปี 2000s

Influenza circulating viruses, positivity rate and risk factors for influenza associated severe acute respiratory infection during 2018/2019 winter season, Yemen

Influenza circulating viruses, positivity rate and risk factors for influenza associated severe acute respiratory infection during 2018/2019 winter season, Yemen

เผยสาเหตุ! ปัจจัยที่ทำให้การติดเชื้อไข้หวัดใหญ่มีอาการรุนแรงขึ้น

How Comorbidities Affect Hospitalization from Influenza in the Pediatric Population

How Comorbidities Affect Hospitalization from Influenza in the Pediatric Population

วิจัยเผย! 80% ของเด็กที่มีโรคประจำตัว เสี่ยง Admit มากกว่า ถ้าติดไข้หวัดใหญ่